²»Á¼Ñо¿Ëù

Weslie Janeway - investor, philanthropist, and scientist - joins ²»Á¼Ñо¿Ëù's Board of Directors.

This collaboration will combine the Mekonos novel ex vivo delivery platform with ²»Á¼Ñо¿Ëù’s opti-ox precision cellular reprogrammin...

Statement from our CFO on the situation concerning SVB.

²»Á¼Ñо¿Ëù will use Automata to automate a key aspect of its production of iPSC derived human cells

Further products in CNS portfolio aim to address the translation gap and accelerate research and drug discovery for neurodegenerat...

New advisors will provide important and independent guidance.

Products aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.

The award was presented at evening ceremony in central London.